Tipsheet

Experts Say Adults Who Contracted COVID-19 and Are Fully Vaccinated Do Not Need to Rush for a Booster Shot

People who have contracted the Wuhan coronavirus and are fully vaccinated do not need to rush to get a booster shot, health experts say.

According to a report from the Wall Street Journal on Sunday, several studies conducted by health experts and scientists show that individuals who’ve had COVID-19 and were fully vaccinated have strong protection against the virus, including variants like the Delta variant, and do not need a booster. The data, which was compiled by experts who specialize in vaccines and immunology, is preliminary and currently incomplete.

Dr. Paul Offit, a member of the Food and Drug Administration’s (FDA) advisory panel on vaccines said to the WSJ that those who were infected and now vaccinated “just won the game.”

“I wouldn’t ask them to get a booster dose. I think they just got it,” Offit explained, meaning that their COVID-19 infection “counts” as their booster. The studies suggest that exposure to COVID-19 effectively serves as a dose of the vaccine, as it prompts the immune system to generate antibodies against the virus for the future. This combination of immunity from real-world exposure and infection compounded with the protection generated from the vaccine is known as “hybrid immunity.”

As we covered, President Biden announced in August that his administration plans to move forward with a coronavirus booster shot program for adults who are fully vaccinated. So far, only the Pfizer coronavirus vaccine booster has received approval from the FDA to be administered to limited age groups. Moderna and Johnson & Johnson have not received approval for their boosters.

Since Biden’s announcement, two top officials at the FDA resigned due to the administration’s interference with booster shots, as Katie reported, claiming there is not enough data to support booster shots across all demographics.

According to CNBC, [t]wo senior Food and Drug Administration officials responsible for reviewing Covid-19 vaccine applications are leaving the federal agency this fall,” and that “[t]heir announced plans to depart come as the Biden administration prepares to begin offering Covid vaccine booster shots to the general public the week of Sept. 20. Some health experts saw the move as premature and political, especially because the FDA hasn’t finished reviewing data on boosters yet.”